ALTJ V35Gy above 50% tripled lymphedema risk after breast radiotherapy
Irradiating more than half of the axillary-lateral thoracic junction to 35 Gy was independently associated with a threefold higher lymphedema risk.
Tag
OAR
Higher immune-cell radiation dose was associated with worse breast cancer-specific survival
Each 1-Gy increase in estimated immune-cell dose was associated with 66% higher breast cancer mortality after multivariable adjustment.
Small gastrointestinal PRV margins limited dose increases but did not encompass pancreatic SABR motion
Two- to five-millimetre gastrointestinal margins usually limited delivered dose increases but frequently failed to encompass interfraction organ motion.
A 4.5 mm margin covered most intrafraction small-bowel motion during MR-guided radiotherapy
A 4.5 mm isotropic margin covered most observed small-bowel occupancy despite craniocaudal displacements exceeding 20 mm in some patients.
Radiotherapy was tolerated without unexpected skin toxicity in epidermolysis bullosa
Four epidermolysis bullosa patients tolerated radiotherapy without greater-than-expected cutaneous toxicity, despite maximum skin dose up to 50.4 Gy.
Higher ovarian dose was linked to ovarian insufficiency after transposition in cervical cancer
All patients receiving more than 8 Gy mean dose or 16 Gy maximum dose to the least exposed ovary developed premature ovarian insufficiency.
Target-prioritized intensity modulated radiotherapy appeared feasible in nasopharyngeal carcinoma near the spinal cord
No radiation myelopathy was observed after target-prioritized intensity modulated radiotherapy for selected nasopharyngeal carcinoma near the spinal cord.
Larger bladder geometry was linked to lower planned bladder dose in prostate radiotherapy
Larger bladder volume was strongly associated with lower planned bladder dose in a static five-fraction prostate radiotherapy analysis.